Pradayrol L[Author] - Search Results

Year	Number of Results
1974	1
1978	4
1979	3
1980	2
1981	7
1982	4
1983	2
1984	3
1985	5
1986	5
1987	3
1988	4
1989	4
1990	5
1991	2
1992	1
1993	1
1994	6
1995	4
1996	7
1997	3
1998	2
1999	2
2000	2
2001	3
2002	10
2003	8
2004	3
2005	10
2006	8
2007	4
2024	0

1

Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.

Fourmy D, Escrieut C, Archer E, Galès C, Gigoux V, Maigret B, Moroder L, Silvente-Poirot S, Martinez J, Fehrentz JA, Pradayrol L. Fourmy D, et al. Among authors: pradayrol l. Pharmacol Toxicol. 2002 Dec;91(6):313-20. doi: 10.1034/j.1600-0773.2002.910608.x. Pharmacol Toxicol. 2002. PMID: 12688374 Review.

2

Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors?

Archer E, Maigret B, Escrieut C, Pradayrol L, Fourmy D. Archer E, et al. Among authors: pradayrol l. Trends Pharmacol Sci. 2003 Jan;24(1):36-40. doi: 10.1016/s0165-6147(02)00009-3. Trends Pharmacol Sci. 2003. PMID: 12498729 Review.

3

Transgenic mice expressing cholecystokinin 2 receptors in the pancreas.

Clerc P, Saillan-Barreau C, Desbois C, Pradayrol L, Fourmy D, Dufresne M. Clerc P, et al. Among authors: pradayrol l. Pharmacol Toxicol. 2002 Dec;91(6):321-6. doi: 10.1034/j.1600-0773.2002.910609.x. Pharmacol Toxicol. 2002. PMID: 12688375 Review.

4

Maternal-fetal transfer of octreotide.

Caron P, Gerbeau C, Pradayrol L. Caron P, et al. Among authors: pradayrol l. N Engl J Med. 1995 Aug 31;333(9):601-2. doi: 10.1056/NEJM199508313330918. N Engl J Med. 1995. PMID: 7623921 No abstract available.

5

A cell cycle-dependent internal ribosome entry site.

Pyronnet S, Pradayrol L, Sonenberg N. Pyronnet S, et al. Among authors: pradayrol l. Mol Cell. 2000 Apr;5(4):607-16. doi: 10.1016/s1097-2765(00)80240-3. Mol Cell. 2000. PMID: 10882097 Free article.

6

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

Archer-Lahlou E, Tikhonova I, Escrieut C, Dufresne M, Seva C, Pradayrol L, Moroder L, Maigret B, Fourmy D. Archer-Lahlou E, et al. Among authors: pradayrol l. J Med Chem. 2005 Jan 13;48(1):180-91. doi: 10.1021/jm049886y. J Med Chem. 2005. PMID: 15634012

7

KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.

Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P. Sirach E, et al. Among authors: pradayrol l. Cell Death Differ. 2007 Jun;14(6):1202-10. doi: 10.1038/sj.cdd.4402114. Epub 2007 Mar 9. Cell Death Differ. 2007. PMID: 17347668

8

Action of prosomatostatin.

Bommelaer G, Pradayrol L, Ribet A. Bommelaer G, et al. Among authors: pradayrol l. Lancet. 1981 Apr 25;1(8226):949. doi: 10.1016/s0140-6736(81)91650-0. Lancet. 1981. PMID: 6112356 No abstract available.

9

Secretin receptors in human pancreatic membranes.

Robberecht P, De Neef P, Waelbroeck M, Camus JC, Scemama JL, Fourmy D, Pradayrol L, Vaysse N, Christophe J. Robberecht P, et al. Among authors: pradayrol l. Pancreas. 1988;3(5):529-35. doi: 10.1097/00006676-198810000-00004. Pancreas. 1988. PMID: 3186683

10

Alternative splicing facilitates internal ribosome entry on the ornithine decarboxylase mRNA.

Pyronnet S, Pradayrol L, Sonenberg N. Pyronnet S, et al. Among authors: pradayrol l. Cell Mol Life Sci. 2005 Jun;62(11):1267-74. doi: 10.1007/s00018-005-5020-8. Cell Mol Life Sci. 2005. PMID: 15905964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

122 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year